Mitigating fuel tank syndrome pelvic injuries - is there potential for rider worn protectors?


Journal

Traffic injury prevention
ISSN: 1538-957X
Titre abrégé: Traffic Inj Prev
Pays: England
ID NLM: 101144385

Informations de publication

Date de publication:
2022
Historique:
pubmed: 11 6 2022
medline: 12 1 2023
entrez: 10 6 2022
Statut: ppublish

Résumé

The aim of this study was to investigate the feasibility of rider-worn pelvis protection for mitigating injury risk when contacting the motorcycle fuel tank in a crash. A newly developed test apparatus was designed and constructed to simulate the interaction between a rider's pelvis and the motorcycle fuel tank in a frontal crash. Impacts were performed at a velocity of 18 km/h into four motorcycle fuel tanks. Further testing used a rigid fuel tank surrogate and the pelvis surrogate in an unprotected condition and with a series of impact protector prototypes. A subset of prototype samples was also tested at varying tank angles (30°, 37.5°, 45°) and impact speeds (8.5 km/h, 13 km/h, 18 km/h). Analysis of variance was used to determine whether the protector prototypes reduced pelvis response compared to unprotected. Resultant peak pelvis acceleration was reduced by three pelvis impact protector prototypes compared to an unprotected condition. The reduction in peak acceleration occurred without a significant change in the peak pelvis rotational velocity. The pattern of protector performance was consistent at varying fuel tank angles but only reduced the pelvis response at the highest impact speed tested of 18 km/h. The results indicate that there may be potential for using pelvis impact protection to mitigate injury risk by absorbing and/or distributing impact energy that would otherwise be transmitted to the rider's pelvis. However, due to the current paucity in understanding of pelvis biomechanics to anteroposterior loading, it is unknown whether the pelvis acceleration reductions achieved would prevent injury.

Identifiants

pubmed: 35687036
doi: 10.1080/15389588.2022.2072834
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

S50-S55

Auteurs

Tom Whyte (T)

Neuroscience Research Australia, Randwick, NSW, Australia.
School of Medical Sciences Faculty of Medicine, The University of New South Wales, NSW, Australia.
The George Institute for Global Health, Newtown, NSW, Australia.

Nicholas Kent (N)

Neuroscience Research Australia, Randwick, NSW, Australia.

Alessandro Cernicchi (A)

Dainese S.p.A, Via, Via Louvigny, Colceresa (VI), Italy.

Julie Brown (J)

Neuroscience Research Australia, Randwick, NSW, Australia.
School of Medical Sciences Faculty of Medicine, The University of New South Wales, NSW, Australia.
The George Institute for Global Health, Newtown, NSW, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH